Virtual Travel Into Nature for Individuals With Lived Experience of Severe Mental Disorders
Launched by DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE · Mar 18, 2025
Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
The aim of this study is to investigate the effect of implementing a virtual reality travel into nature application (Toujours Dimanche) in an inpatient psychiatric unit servicing individuals with complex mood disorders. Via a head mounted device, the application allows individuals to immerse themselves into 360 natural environments and offers the possibility to interact with another individual through a private platform. Recruitment will take place on a psychiatric inpatient unit dedicated to individuals with complex mood disorders (e.g. bipolar disorder, unipolar depression). Flyers will b...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being 18 years old or older
- • Being hospitalized in a psychiatric unit at the time of the study
- • Being relatively clinically stable, according to the treating psychiatrist
- • Being free of uncorrected visual impairments
- • Being able to speak or read French or English
- Exclusion Criteria:
- • Current photosensitive epilepsy or a history of seizures
- • Previous history of severe motion sickness or cyber-sickness
About Douglas Mental Health University Institute
The Douglas Mental Health University Institute is a leading research and clinical facility dedicated to advancing the understanding and treatment of mental health disorders. Affiliated with McGill University, the institute integrates cutting-edge scientific research with clinical practice to foster innovation in mental health care. Focused on collaborative and interdisciplinary approaches, the Douglas Institute conducts a range of clinical trials aimed at developing new therapeutic strategies and improving patient outcomes. Its commitment to excellence in research, education, and community service positions it as a vital contributor to the field of mental health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Montreal, Quebec, Canada
Patients applied
Trial Officials
Élisabeth Thibaudeau, Ph.D.
Principal Investigator
Laval University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported